SUMMARY The aim of this study was to determine the feasibility of inducing a prolonged coma in severely asphyxiated newborn babies by the infusion of high dose thiopentone. In six severely asphyxiated babies the electroencephalograph (EEG) Babies born without a heart beat who despite resuscitation do not start to breathe spontaneously within the first half hour after birth have a poor outcome.1-3 In a large study babies with an Apgar score of three or less for more than 20 minutes had a mortality of 87% and the rate of cerebral palsy in survivors was 57%.4 Monitoring of heart rate and sonography are used to identify the fetus at risk of intrapartum asphyxia, but despite this some are born profoundly asphyxiated. Although death results from damage to organs other than the brain, long term morbidity is almost exclusively a consequence of impaired brain function.
SUMMARY The aim of this study was to determine the feasibility of inducing a prolonged coma in severely asphyxiated newborn babies by the infusion of high dose thiopentone. In six severely asphyxiated babies the electroencephalograph (EEG) and blood pressure were monitored continuously. Thiopentone was infused at a rate sufficient to suppress completely the EEG providing the mean blood pressure remained above 35 mm Hg; it was continued until there was no evidence of cerebral oedema for 24 hours. In two the infusion was stopped prematurely because of hypotension that was unresponsive to treatment. In the other four a deep coma was maintained for a median duration of 127 hours. All developed pharmacodynamic tolerance to the thiopentone and showed non-linear elimination kinetics. Three babies died; the three survivors have moderate to severe handicap. It was concluded that with full intensive care it is possible to induce a deep coma; the outcome does not seem to complications was high.
Babies born without a heart beat who despite resuscitation do not start to breathe spontaneously within the first half hour after birth have a poor outcome.1-3 In a large study babies with an Apgar score of three or less for more than 20 minutes had a mortality of 87% and the rate of cerebral palsy in survivors was 57%.4 Monitoring of heart rate and sonography are used to identify the fetus at risk of intrapartum asphyxia, but despite this some are born profoundly asphyxiated. Although death results from damage to organs other than the brain, long term morbidity is almost exclusively a consequence of impaired brain function.
There is debate about the management of postasphyxial encephalopathy. Severe restriction of fluid intake to reduce production of cerebrospinal fluid and prevent cerebral oedema has not been shown to be beneficial and may result in depletion of intravascular volume and hypotension.5 Hyperventilation decreases raised intracranial pressure only by reducing cerebral blood flow; if there is associated hypotension from myocardial ischaemia or hypovolaemia hyperventilation may lead to further neuronal injury. Although In view of these findings we designed a study to investigate the possibility of using treatment with high dose barbiturate for newly born babies who had sustained very severe intrapartum asphyxia.
Patients and methods
Babies born between May 1980 and December 1982 in the John Radcliffe Maternity Hospital, Oxford, were eligible for the study if there was no heart beat at birth and despite resuscitation they failed to establish spontaneous respiration within 20 minutes after birth. Babies with obvious lethal congenital malformations were excluded.
Thiopentone was selected as the most appropriate barbiturate because it is highly lipid soluble; thus high concentrations can be achieved in neurones within seconds of an intravenous bolus.
After resuscitation had been performed and a regular heart beat established the babies were transferred to the intensive care nursery. The possible benefits and side effects of an infusion of thiopentone were discussed with one or both parents as soon as possible and before starting the infusion. Their consent for this treatment was obtained. Umbilical arterial and venous catheters were inserted and the aortic blood pressure and the central venous blood pressure were monitored continuously. A two channel EEG was recorded continuously, using a method described previously. 2 All babies received intermittent positive pressure ventilation, and arterial blood gases were measured at least four hourly. The oxygen tension was maintained between 6-6 and 11-3 kPa (50-85 mm Hg) and the carbon dioxide tension between 3-7 and 4-6 kPa (28-35 mm Hg). The intake of non-colloid fluid was 60 m/kg/24h, given intravenously.
An ultrasound scan of the brain was performed daily. Myocardial function was assessed by electrocardiograph (ECG) daily and by echocardiography. Blood glucose concentration was measured three hourly, plasma thiopentone concentration six hourly, and plasma electrolyte concentrations and liver function tests daily.
The infusion of thiopentone was continued until there was a 24 hour period with no evidence of raised intracranial pressure based on clinical examination and cerebral ultrasonography. Babies who died had a postmortem examination, which ( Fig. 2) . The rate of thiopentone clearance was not constant, rather it slowly increased with time, indicating the presence of non-linear elimination kinetics. Cases 3 and 6 began to show clinical evidence of cerebral activity (movement in response to a noxious stimulus) at plasma thiopentone concentrations of less than 187 and 165 ,umol/I 101 and 107 hours, respectively, after the infusion had been stopped. Case 4 sustained brain death and showed no clinical evidence of cerebral activity when the serum thiopentone concentrations were unrecordable.
The major side effects were dose dependent cardiovascular and respiratory depression. The loading dose of thiopentone suppressed all spontaneous respiratory effort; all babies received intermittent positive pressure ventilation, the median period being 9-5 days, with a range of 3-20 days. In addition, four babies had early respiratory problems attributed to asphyxial lung injury. Soon after birth all six babies had ECG and ultrasound evidence of myocardial ischaemia or infarction. In all the heart rate and blood pressure fell after the beginning of the infusion of thiopentone (Fig. 3) . In two (cases 2 and 5) an infusion of dopamine was used to support myocardial function. All six babies had clinical evidence of acute tubular necrosis and all had initial low plasma calcium concentrations (less than 1-5 mmol/l (6mg/100ml)); two (cases 3 and 6) had one   0  24  48  72  96  120   141   168  192  216 240  264  288  312 Time (h) Fig. 3 Rate of infusion and plasma concentrations of thiopentone for case 3 in relation to heart rate and blood pressure. hypoglycaemic episode (less than 1-1 mmol/l (19-8 mg/100 ml)). Three babies died (cases 3, 4, and 5), and three survived with serious disabilities (cases 1, 2, and 6). The outcome of the babies is tabulated in Table 2 .
Discussion
The poor outcome of the survivors of this study was disappointing. The explanation may lie in the delay from the onset of cerebral ischaemia to the administration of the thiopentone. In the babies the neuronal ischaemia must have begun during labour and it is therefore difficult to determine the exact time of onset for each baby. Only two babies had cardiac tocographic monitoring during labour: both had evidence of fetal distress for more than two and a half hours before delivery. In addition, there was a delay from birth to the administration of thiopentone. During this time resuscitation was performed, the baby transferred to the intensive care nursery, catheters placed in the aorta and inferior vena cava, monitoring of pressure begun, and parental consent obtained. The total time from the onset of neuronal ischaemia to administration of thiopentone may have been up to four hours. Animal studies have shown a beneficial effect from thiopentone only when it was administered up to two hours after the onset of neuronal ischaemia.
The major side effect of the infusion of thiopentone was cardiovascular suppression. It has been shown that this myocardial toxicity will be potentiated if the myocardium is compromised or if intravascular volume is depleted. There was clinical evidence of myocardial ischaemia in all six babies studied, and cardiovascular suppression was evident in all six immediately after administering the first dose of thiopentone. If episodes of hypotension and thus further cerebral ischaemia are to be avoided in very severely asphyxiated babies it is important to monitor both arterial and central venous blood pressures before starting the infusion of thiopentone. In addition, it is necessary to assess cardiac function regularly by clinical examination, ECG, and echocardiography. To keep the EEG suppressed the serum thiopentone concentrations had to be progressively increased. A similarly rapid onset of pharmacodynamic tolerance has been described previously in adult patients,22 but its mechanism is unknown. The rapid development of tolerance makes continuous recording of the EEG mandatory as it provides the only guide to the necessary rate of infusion of the thiopentone. Thiopentone is almost completely metabolised by a hepatic microsomal system, with only 03% being recovered unaltered in human urine.23 When used in low doses (5 mg/kg) for example, as a bolus for the induction of anaesthesia thiopentone shows first order kinetics with a half life in neonates double that of adults (16 hours and eight hours, respectively).23 In this study after prolonged administration thiopentone showed non-linear kinetics, and initially there was a very slow clearance of thiopentone from the blood. This non-linearity is probably a consequence of the saturation of the hepatic enzyme system that oxidises thiopentone to an inactive carboxylic acid metabolite. This has important therapeutic implications: when the infusion is stopped after a prolonged period the subjects remained comatosed for many days. Intensive care must continue during this time, and it is impossible to make a detailed assessment of neurological function. Such a long period of coma and uncertainty immediately after a difficult delivery is stressful both to the parents and to the medical and nursing staff caring for the baby.
This study shows that treatment with high dose thiopentone is possible in the newborn after severe intrapartum asphyxia but that it requires full intensive care and extremely close medical and nursing supervision. When begun one to two hours after birth the outcome does not seem to be improved and the incidence of complications is high.
